These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6641231)

  • 21. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspects of clinic monitoring in large-scale multiclinic trials.
    Mowery RL; Williams OD
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):717-9. PubMed ID: 373961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of monitoring practices in cancer clinical trials.
    George SL
    Stat Med; 1993 Mar; 12(5-6):435-50. PubMed ID: 8493422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learned from the DIG trial.
    Egan D; Geller N; Yusuf S; Garg R; Collins JF; Mathew J; Philbin E;
    Control Clin Trials; 2003 Dec; 24(6 Suppl):316S-326S. PubMed ID: 14643078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of the long-term controlled trials of usefulness of therapy for systemic hypertension.
    Gifford RW
    Am J Cardiol; 1989 Jan; 63(4):8B-16B. PubMed ID: 2563189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for treating mild hypertension.
    Moser M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S102-8. PubMed ID: 2580160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some operational aspects of the Veterans Administration Cooperative Studies Program from 1972 to 1979.
    Henderson WG
    Control Clin Trials; 1980 Dec; 1(3):209-26. PubMed ID: 7261614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The MRFIT, HDFP and Oslo studies: the important data. Multiple Risk Factor Intervention Trial. Hypertension Detection and Follow-up Program].
    Svärdsudd K
    Cardiologia; 1984; 29(1-2):53-62. PubMed ID: 6398706
    [No Abstract]   [Full Text] [Related]  

  • 29. The employee high blood pressure program of the National Institutes of Health.
    Wasserman BP
    Public Health Rep; 1982; 97(2):122-6. PubMed ID: 7063592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group.
    Circulation; 1984 Dec; 70(6):996-1003. PubMed ID: 6388901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress toward prevention of cardiovascular disease. A 30-year retrospective.
    Levy RI
    Circulation; 1979 Dec; 60(7):1555-9. PubMed ID: 387282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.
    Jones SP; Tang XL; Guo Y; Steenbergen C; Lefer DJ; Kukreja RC; Kong M; Li Q; Bhushan S; Zhu X; Du J; Nong Y; Stowers HL; Kondo K; Hunt GN; Goodchild TT; Orr A; Chang CC; Ockaili R; Salloum FN; Bolli R
    Circ Res; 2015 Feb; 116(4):572-86. PubMed ID: 25499773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial monitoring: hit or miss?
    Cohen J
    Science; 1994 Jun; 264(5165):1534-7. PubMed ID: 8202707
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypertension detection and follow-up program(HDFP)].
    Atarashi K; Sugimoto T
    Nihon Rinsho; 1992 Apr; 50 Suppl():188-94. PubMed ID: 1635190
    [No Abstract]   [Full Text] [Related]  

  • 36. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group.
    JAMA; 1988 Apr; 259(14):2113-22. PubMed ID: 3346988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recruitment in NHLBI population-based studies and randomized clinical trials: data analysis and survey results.
    Probstfield JL; Wittes JT; Hunninghake DB
    Control Clin Trials; 1987 Dec; 8(4 Suppl):141S-149S. PubMed ID: 3440387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods of quality control and of continuous audit procedures for controlled clinical trials.
    Knatterud GL
    Control Clin Trials; 1981 May; 1(4):327-32. PubMed ID: 7261623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruitment in the hypertension detection and follow-up program.
    Ford CE; Langford HG; Palmer MJ
    Control Clin Trials; 1987 Dec; 8(4 Suppl):54S-67S. PubMed ID: 3440390
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.